Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Journal of Virus Eradication
|
October 6, 2021
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach
Jasmini Alagaratnam, Wolfgang Stöhr, Jamie Toombs, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Nature Communications
|
October 6, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
The Journal of Infectious Diseases
|
July 20, 2005
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection
Sabine Kinloch-de Loes, Bruno Hoen, Don E Smith, et al.
Research Square
|
March 24, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Cytotherapy
|
December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Nature Communications
|
October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
Scientific Reports
|
November 4, 2023
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri-Bowen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 30, 2007
Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005
Bruno Hoen, David A Cooper, Fiona C Lampe, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Journal of Virus Eradication
|
October 6, 2021
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach
Jasmini Alagaratnam, Wolfgang Stöhr, Jamie Toombs, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Nature Communications
|
October 6, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
The Journal of Infectious Diseases
|
July 20, 2005
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection
Sabine Kinloch-de Loes, Bruno Hoen, Don E Smith, et al.
Research Square
|
March 24, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Cytotherapy
|
December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Nature Communications
|
October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
Scientific Reports
|
November 4, 2023
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri-Bowen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 30, 2007
Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005
Bruno Hoen, David A Cooper, Fiona C Lampe, et al.
Page
of 7